Promethera Biosciences

Promethera Biosciences

Promethera Biosciences

Promethera Biosciences is a biopharmaceutical company focused on cell therapyproducts to treat liver diseases.
Suggest edits
Founded
2009
Raised
$92.9M
Follow us
Companies in the same industry
Alexa global traffic share
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 5

Add info
Add round
10 Apr 2018
€9,300,000
Debt financing
Shinsei Corporate Investment Limited, Shibuya Corporation

Promethera Biosciences Raises Additional €9.3M in Funding

FinSMEs
27 Oct 2016
€10,000,000
Venture capital (Series C)
Mitsui & Co. Global Investment, Mitsubishi UFJ Capital, Boehringer Ingelheim Venture Fund, +4

Promethera Biosciences Raises EUR 10 Million in a Series C-extension Financing to Advance its Broad Product Pipeline in Liver Diseases | Business Wire

businesswire
25 Nov 2014
$31,444,456
Venture capital (Series C)
28 Mar 2012
$31,475,320
Venture capital (Series B)
Mitsui & Co. Global Investment, Boehringer Ingelheim Venture Fund, Shire
02 Feb 2010
$7,300,000
Venture capital (Series A)
Life Sciences Partners, Société Régionale d'Investissement de Wallonie, Vesalius Biocapital